Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01365247 · ClinicalTrials.gov registry record · NA

Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD)

A NA study, sponsored by The City College of New York.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT01365247 is a NA study that has completed, run by The City College of New York. The registered enrollment target is 110 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01365247, a NA study, has completed, sponsored by The City College of New York.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

This treatment intervention trial is designed for men and women with substance dependence and comorbid Post-Traumatic Stress Disorder (PTSD). Participants will be randomly assigned to one of three conditions (two behavioral treatments \[Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure and Relapse Prevention Therapy\] and an active monitoring control group) and will be evaluated at baseline and four follow-up points (post-treatment, 1-month, 2- month and 3-month post-treatment).

Interventions

  • BEHAVIORAL Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure
  • BEHAVIORAL Relapse Prevention Treatment
  • BEHAVIORAL Active Monitoring Control Group

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2008-09
Est. Completion 2014-12
Phase NA

Sponsor

The City College of New York

7 total trials

What the Registry Record Tells You About NCT01365247

The ClinicalTrials.gov registry entry for NCT01365247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The City College of New York, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure is the first listed.

NCT01365247 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01365247 about?

NCT01365247 is a clinical study titled "Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD)". This treatment intervention trial is designed for men and women with substance dependence and comorbid Post-Traumatic Stress Disorder (PTSD). Participants will be randomly assigned to one of three conditions (two behavioral treatments \[Concurrent Treatment of PTSD and Substance Use Disorders Using ...

What is the current status of trial NCT01365247?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2008-09. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01365247?

The interventions under investigation include: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (BEHAVIORAL), Relapse Prevention Treatment (BEHAVIORAL), Active Monitoring Control Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01365247?

This trial is sponsored by The City College of New York, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.